2021.03至今 中國(guó)科學(xué)院廣州生物醫(yī)藥與健康研究院 副研究員

2018.08-2021.02 廣州醫(yī)科大學(xué)附屬第三醫(yī)院 博士后

2013.09-2018.07 中國(guó)科學(xué)院大學(xué) 博士

2009.09-2013.07 華南農(nóng)業(yè)大學(xué) 學(xué)士

1.肺癌轉(zhuǎn)移的機(jī)制；

2.靶向腫瘤微環(huán)境的免疫治療。

1. 國(guó)家自然科學(xué)基金青年項(xiàng)目，82003054，MDSC-腫瘤細(xì)胞正向反饋促進(jìn)非小細(xì)胞肺癌轉(zhuǎn)移的機(jī)制研究，2021.1-2023-12，項(xiàng)目負(fù)責(zé)人。

2. 廣東省基礎(chǔ)與應(yīng)用基礎(chǔ)研究基金項(xiàng)目，2019A1515110084，MDSC來(lái)源的CCL11促進(jìn)NSCLC的間充質(zhì)樣轉(zhuǎn)變和轉(zhuǎn)移的機(jī)制研究，2020.1-2021.12，項(xiàng)目負(fù)責(zé)人。

3. 第64批中國(guó)博士后科學(xué)基金面上資助，2018M640771，地貧小鼠模型的建立及基因編輯治療地貧的臨床前評(píng)估，2018.11-2021.2，項(xiàng)目負(fù)責(zé)人。

廣東省科技進(jìn)步二等獎(jiǎng) “人源化小鼠及其臨床前評(píng)估平臺(tái)的建立及應(yīng)用“（2019, 7/10）

1. Lin, Shouheng#; Zhang, Xuchao#; Huang, Guohua#; Cheng, Lin#; Lv, Jiang; Zheng, Diwei; Lin, Simiao; Wang, Suna; Wu, Qiting; Long, Youguo; Li, Baiheng; Wei, Wei; Liu, Pentao; Pei, Duanqing; Li, Yangqiu; Wen, Zhesheng; Cui, Shuzhong; Li, Peng; Sun, Xiaofang*; Wu, Yilong*; Yao, Yao*; Myeloid-derived suppressor cells promote lung cancer metastasis by CCL11 to activate ERK and AKT signaling and induce epithelial-mesenchymal transition in tumor cell,Oncogene,2021 Feb;40(8):1476-1489.

2. Lin, Shouheng; Cheng, Lin; Ye, Wei; Li, Shanglin; Zheng, Diwei; Qin, Le; Wu, Qiting; Long, Youguo; Lin, Simiao; Wang, Suna; Huang, Guohua; Li, Peng; Yao, Yao*; Sun, Xiaofang*; Chimeric CTLA4-CD28-CD3z T Cells Potentiate Antitumor Activity Against CD80/CD86-Positive B Cell Malignancies, Frontiers in Immunology, 2021 Apr 2;12:642528.

3. Lin, Shouheng#; Huang, Guohua#; Cheng, Lin#; Li, Zhen; Xiao, Yiren; Deng, Qiuhua; Jiang, Yuchuan; Li, Baiheng; Lin, Simiao; Wang, Suna; Wu, Qiting; Yao, Huihui; Cao, Su; Li, Yang; Liu, Pentao; Wei, Wei; Pei, Duanqing; Yao, Yao; Wen, Zhesheng; Zhang, Xuchao; Wu, Yilong; Zhang, Zhenfeng; Cui, Shuzhong; Sun, Xiaofang; Qian, Xueming*; Li, Peng*; Establishment of peripheral blood mononuclear cell-derived humanized lung cancer mouse models for studying efficacy of PD-L1/PD-1 targeted immunotherapy, mAbs, 2018, 10(8): 1301-1311.

4. Lin, Shouheng#; Huang, Guohua#; Xiao, Yiren; Sun, Wei; Jiang, Yuchuan; Deng, Qiuhua; Peng, Muyun; Wei, Xinru; Ye, Wei; Li, Baiheng; Lin, Simiao; Wang, Suna; Wu, Qiting; Liang, Qiubin; Li, Yangqiu; Zhang, Xuchao; Wu, Yilong; Liu, Pentao; Pei, Duanqing; Yu, Fenglei; Wen, Zhesheng; Yao, Yao; Wu, Donghai*; Li, Peng*; CD215 Myeloid Cells Respond to Interleukin 15 Stimulation and Promote Tumor Progression, Frontiers in Immunology, 2017, 8: 1713.

5. Lai, Yunxin; Wei, Xinru; Lin, Shouheng; Qin, Le; Cheng, Lin; Li, Peng*; Current status and perspectives of patient-derived xenograft models in cancer research, Journal of Hematology & Oncology, 2017, 10(1): 106.

6. Xiong, Zeyu; Xie, Yingjun; Yang, Yi; Xue, Yanting; Wang, Ding; Lin, Shouheng; Chen, Diyu; Lu, Dian; He, Lina; Song, Bing; Yang, Yinghong; Sun, Xiaofang*；Efficient gene correction of an aberrant splice site in beta-thalassaemia iPSCs by CRISPR/Cas9 and single-strand oligodeoxynucleotides，Journal of Cellular and Molecular Medicine, 2019, 23(12): 8046-8057.?

7.Chang, Yanqun; Lin, Shouheng; Li, Yongsheng*; Liu, Song; Ma, Tianbao; Wei, Wei； Umbilical cord blood CD34(+) cells administration improved neurobehavioral status and alleviated brain injury in a mouse model of cerebral palsy，Childs Nerv Syst, 2021, 37(7): 2197-2205.?

8.Jiang, Zhiwu; Wu, Di; Lin, Shouheng; Li, Peng*； CD34 and CD38 are prognostic biomarkers for acute B lymphoblastic leukemia，Biomark Res, 2016, 4: 23.

9. Lin, Shouheng; Zhao, Ruocong; Xiao, Yiren; Li, Peng*；Mechanisms determining the fate of hematopoietic stem cells，Stem Cell Investig, 2015, 2: 10.?

?